Starting today, anyone who visits the online retailer Amazon will soon be able to review manuscripts, just like pens, sneakers, and toiletry products.
With a new partnership with F1000, Wellcome embraces sketchy peer review standards, deep conflicts of interest, and financial support of a private, commercial enterprise. Worse, the entire thing seems redundant, avoidable, and unnecessary.
Peerage of Science’s Janne-Tuomas Seppänen discusses their new peer review offering for authors and journals.
All primary data should be made openly available, a UK government report recommends.
Do the benefits of open peer-review outweigh the costs? A BMJ study argues “yes,” but there are caveats.